HR 9635
  • Introduced
    Jul 09, 2026
  • Passed House
  • Passed Senate
  • Became Law
HR 9635
United States House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.
Last Action See all actions
House • Jul 09, 2026: Referred to the House Committee on Energy and Commerce.

Summary

Comments on HR 9635

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Jul 09, 2026 | House
    • Introduced in House
    • Referred to the House Committee on Energy and Commerce.
Bill Texts
Looks like there aren't any bill texts available at this moment.
Documents
Looks like we don't have any documents available at this moment.
Sources